Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $110.5000 (-0.32%) ($109.2100 - $111.2300) on Mon. Jan. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.72% (three month average) | RSI | 69 | Latest Price | $110.5000(-0.32%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 2.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(46%) SPLV(36%) VYM(34%) XLP(33%) DIA(32%) | Factors Impacting ABBV price | ABBV will decline at least -0.86% in a week (0% probabilities). VIXM(-24%) UUP(-10%) VXX(-4%) IGOV(-2%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.86% (StdDev 1.72%) | Hourly BBV | -0.9 () | Intraday Trend | 0.7% | | | |
|
5 Day Moving Average | $111.48(-0.88%) | 10 Day Moving Average | $111.1(-0.54%) | 20 Day Moving Average | $108.48(1.86%) | To recent high | -1.9% | To recent low | 37.3% | Market Cap | $194.953b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |